載入...
Immunotherapy strategy of EGFR mutant lung cancer
EGFR-mutant lung cancer is an important molecular subtype in Asia considering that almost 40%-50% of patients with lung adenocarcinoma in Asian carry the active EGFR mutaiton. People have greatly anticipated the efficacy of PD-1/PD-L1 monoclonal antibody in lung cancer treatment but anti-PD-1/PD-L1...
Na minha lista:
| 發表在: | Am J Cancer Res |
|---|---|
| Main Authors: | , , , , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
e-Century Publishing Corporation
2018
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6220136/ https://ncbi.nlm.nih.gov/pubmed/30416860 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|